Label Changes for:
Ultane and Ultane NovaPlus (Sevoflurane) Volatile Liquid for Inhalation
Changes have been made to the WARNINGS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2012
- e.g., patients with congenital Long QT Syndrome or patients taking drugs that can prolong the QT interval).